Showing results (551-560 of 562) with videos related to
Sort By:
Pageof 57
BJOG : an International Journal of Obstetrics and Gynaecology|March 27, 2014
Uterine sutures at prior caesarean section and placenta accreta in subsequent pregnancy: a case-control studyS Sumigama, C Sugiyama, T Kotani, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 13, 2012
Updated overall survival results from a randomized phase III trial comparing gefitinib with carboplatin-paclitaxel for chemo-naïve non-small cell lung cancer with sensitive EGFR gene mutations (NEJ002)A Inoue, K Kobayashi, M Maemondo, et al.Oncogene|December 1, 2015
Inactivating mutations in GNA13 and RHOA in Burkitt's lymphoma and diffuse large B-cell lymphoma: a tumor suppressor function for the Gα13/RhoA axis in B cellsM O'Hayre, A Inoue, I Kufareva, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 12, 2015
Randomized phase II study of concurrent versus sequential alternating gefitinib and chemotherapy in previously untreated non-small cell lung cancer with sensitive EGFR mutations: NEJ005/TCOG0902S Sugawara, S Oizumi, K Minato, et al.ACS Omega|May 19, 2025
Valorization of Fish Waste Using Biochar and Crude Glycerin as Additives in CompostingBrenda K V Leite, Ana C A Orrico, Marco A P Orrico Junior, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 25, 2015
A randomized phase III trial of oral S-1 plus cisplatin versus docetaxel plus cisplatin in Japanese patients with advanced non-small-cell lung cancer: TCOG0701 CATS trialK Kubota, H Sakai, N Katakami, et al.Journal of Viral Hepatitis|August 15, 2009
Factors affecting efficacy in patients with genotype 2 chronic hepatitis C treated by pegylated interferon alpha-2b and ribavirin: reducing drug doses has no impact on rapid and sustained virological responsesY Inoue, N Hiramatsu, T Oze, et al.Journal of Viral Hepatitis|April 11, 2014
Risk factors for hepatocellular carcinoma in hepatitis C patients with normal alanine aminotransferase treated with pegylated interferon and ribavirinN Harada, N Hiramatsu, T Oze, et al.Journal of Viral Hepatitis|June 26, 2009
Pegylated interferon alpha-2b (Peg-IFN alpha-2b) affects early virologic response dose-dependently in patients with chronic hepatitis C genotype 1 during treatment with Peg-IFN alpha-2b plus ribavirinT Oze, N Hiramatsu, T Yakushijin, et al.Bioorganic & Medicinal Chemistry Letters|September 29, 2009
Discovery of a potent, metabolically stabilized resorcylic lactone as an anti-inflammatory leadH Du, T Matsushima, M Spyvee, et al.Pageof 57